Immune drug trial aims to ease diabetes burden in kids with rare fat disorder
NCT ID NCT03936829
Summary
This study is testing if a drug called cyclophosphamide can help children who have both a rare autoimmune fat-loss condition (lipodystrophy) and type 1 diabetes. The drug aims to calm the immune system to improve how the body uses insulin, potentially lowering the very high insulin doses these children need. It involves a small group of 10 participants to see if this approach makes blood sugar easier to manage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.